Toulouse, August 30, 2022, 6:10 p.m.
BOYDSense SAS, subsidiary of Alpha MOS (Euronext Paris, ISIN: FR0013421286 ALNEO),
was chosen in December 2021 by the EIC under its Horizon Europe funding program (2021-2027), co-managed with the European Commission (EC).
Obtaining the first part of this non-dilutive financing of €2.5 million
now allows BOYDSense to cross several key stages in the development and industrialization of its non-invasive product. First, the recruitment of engineers and scientists for the R&D department in Toulouse, then the acceleration of clinical trials in Europe to rapidly validate the device. The EIC’s assistance will also enable the company to obtain ISO 13485 certification, a necessary step to comply with international medical device regulations.
Finally, more prototypes will be produced: the clinical trials conducted in parallel will thus make it possible to obtain clinical evidence more quickly.
”
This grant will help us generate more clinical trial data and therefore improve our algorithms. This is a big step for BOYDSense and patients with diabetes as blood glucose monitoring by injection may soon be replaced by non-invasive measurements.
said Ben Delhey, CEO of BOYDSense.
About BOYDSense
BOYDSense, SAS. is a medical technology company developing an affordable, non-invasive health monitoring platform to measure different biomarkers via exhaled breath.
Breath-based metabolomics focuses on capturing, identifying, and quantifying biomarker patterns of volatile organic compounds (VOCs) in human breath and using them to diagnose and monitor chronic diseases, such as diabetes. . The BOYDSense platform will also enable consumers and healthcare providers to use breath as a non-invasive way to detect and monitor diseases such as cancer, obesity, asthma, and more.
BOYDSense’s first product under development, named Lassie™ is an affordable device that allows people with diabetes to accurately measure blood glucose values without cost or pain.
BOYDSense is a subsidiary of Alpha MOS, leader in sensory analysis.
For more information: www.boydsense.com.
About Alpha MOS
Alpha MOS (Euronext Paris, ISIN: FR0013421286 ALM, Mnemonic code: ALNEO) specialist in sensory analysis solutions, is the world leader in the manufacture of electronic noses, tongues and eyes for industrial use. Founded in 1993, Alpha MOS is an international company established in France, China and the United States. It manages a fleet of more than 1,000 instruments installed throughout the world, spread over the food-processing sectors, the beverage and packaging industries mainly. Alpha MOS continually invests in research and development to meet market needs and innovates to develop consumer sensory analysis markets.?
For more information: www.alpha-mos.com
Company contacts
BOYDSense: Ben Delhey – CEO – + 491635570055
Alpha MOS: Pierre Sbabo – CEO – 05 62 47 53 80
Press contacts
Lucas Rennesson – Mascaret –
[email protected]
– 06 30 76 97 61
This post has the “? Actusnews SECURITY MASTER” service.
– SECURITY MASTER Key:
x2hxYZiaZmfGxptwl5mXaWpjb22Vw5PHbGHKmmhrlZaUbHBmxWmVZpyeZnBnlWdn
– To check this key:
https://www.security-master-key.com.
Regulated information:
Inside information:
– Other press releases
Full and original press release in PDF format:
https://www.actusnews.com/news/76021-2022-08-30-cp-eic-boydsense-en.pdf
© Copyright Actusnews Wire
Receive the company’s next press releases free of charge by email by subscribing to www.actusnews.com